Largest health care pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 health care pharmaceutical companies ranked by total liabilities, at SAR 514.6B, ahead of Pfizer (SAR 455.3B) and Johnson & Johnson (SAR 441.4B). Figures as of 19 Nov 2026, 18:32 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieSAR 514.6B
- Median
- SAR 7.8B
- Combined market value
- SAR 18.66T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SAR 514.6B | SAR 1.88T | SAR 1,061.46 | 1.06% down | 25% up | ||
| 2 | PfizerPFE · Health Care | SAR 455.3B | SAR 591.5B | SAR 103.77 | 1.41% down | 15% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | SAR 441.4B | SAR 2.41T | SAR 1,001.67 | 2.08% down | 34% up | ||
| 4 | Eli LillyLLY · Health Care | SAR 322.4B | SAR 4.53T | SAR 5,083.09 | 2.00% down | 33% up | ||
| 5 | Merck & CoMRK · Health Care | SAR 315.8B | SAR 1.23T | SAR 497.63 | 3.71% down | 45% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | SAR 268.3B | SAR 450.5B | SAR 220.37 | 1.36% down | 30% up | ||
| 7 | AstraZenecaAZN · Health Care | SAR 245.1B | SAR 1.02T | SAR 658.11 | 1.85% down | 1% up | ||
| 8 | NovartisNVS · Health Care | SAR 241.6B | SAR 1.08T | SAR 569.63 | 2.16% down | 25% up | ||
| 9 | SanofiSNY · Health Care | SAR 229.3B | SAR 414.9B | SAR 172.77 | 2.25% down | 4% down | ||
| 10 | GSKGSK · Health Care | SAR 224.9B | SAR 360.7B | SAR 179.94 | 1.26% down | 5% up | ||
| 11 | Novo NordiskNVO · Health Care | SAR 194.2B | SAR 642.2B | SAR 145.71 | 1.48% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | SAR 189.8B | SAR 256.6B | SAR 80.33 | 0.68% up | 51% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | SAR 127.3B | SAR 676.1B | SAR 390.37 | 0.39% down | 16% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SAR 123.2B | SAR 172B | SAR 147.38 | 6.96% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | SAR 84.3B | SAR 85.6B | SAR 74.70 | 1.80% down | 99% up | ||
| 16 | GrifolsGRFS · Health Care | SAR 50.4B | SAR 21.1B | SAR 31.04 | 2.30% down | 0% up | ||
| 17 | ZoetisZTS · Health Care | SAR 45.5B | SAR 125.2B | SAR 308.26 | 3.96% down | 26% down | ||
| 18 | Royalty PharmaRPRX · Health Care | SAR 37.2B | SAR 146.7B | SAR 255.11 | 0.96% down | 79% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | SAR 34.9B | SAR 363.7B | SAR 3,516.19 | 0.86% down | 28% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | SAR 27.5B | SAR 57.5B | SAR 896.04 | 3.59% down | 41% up | ||
| 21 | GenmabGMAB · Health Care | SAR 26.4B | SAR 119.3B | SAR 193.53 | 1.23% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | SAR 26.2B | SAR 497.9B | SAR 1,963.95 | 2.40% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | SAR 25.5B | SAR 49.8B | SAR 99.55 | 0.60% down | 26% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SAR 15.7B | SAR 75.1B | SAR 560.85 | 0.08% up | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | SAR 14.4B | SAR 172.4B | SAR 1,509.35 | 0.30% down | 16% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | SAR 13.8B | SAR 27.9B | SAR 80.16 | 2.33% down | 90% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | SAR 11.6B | SAR 18.6B | SAR 222.21 | 1.64% down | 21% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | SAR 11.4B | SAR 16.8B | SAR 100.92 | 1.77% down | 63% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | SAR 11.3B | SAR 57.4B | SAR 294.79 | 0.74% up | 21% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 7.9B | SAR 46.6B | SAR 55.86 | 0.59% down | 8% up | ||
| 31 | CytokineticsCYTK · Health Care | SAR 7.8B | SAR 26.9B | SAR 193.33 | 0.43% up | 19% down | ||
| 32 | Ascendis PharmaASND · Health Care | SAR 6.1B | SAR 63.6B | SAR 969.99 | 4.34% down | 29% up | ||
| 33 | InsmedINSM · Health Care | SAR 5.7B | SAR 117B | SAR 533.45 | 18.71% up | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | SAR 5.7B | SAR 45.5B | SAR 235.04 | 2.00% up | 17% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 3.3B | SAR 23.1B | SAR 163.06 | 0.84% up | 13% up | ||
| 36 | United TherapeuticsUTHR · Health Care | SAR 2.9B | SAR 90B | SAR 2,112.23 | 2.46% down | 22% up | ||
| 37 | Legend BiotechLEGN · Health Care | SAR 2.7B | SAR 11.6B | SAR 59.98 | 1.60% down | 41% down | ||
| 38 | AlkermesALKS · Health Care | SAR 2.5B | SAR 29.1B | SAR 173.11 | 1.49% down | 66% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 2.5B | SAR 34.6B | SAR 1,489.05 | 0.28% down | 27% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | SAR 2.3B | SAR 26.6B | SAR 505.97 | 0.66% up | 6% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | SAR 2B | SAR 21.8B | SAR 1,089.14 | 2.80% down | 50% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SAR 2B | SAR 23.4B | SAR 358.15 | 3.23% up | 34% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | SAR 1.8B | SAR 17.6B | SAR 183.78 | 2.48% down | 45% up | ||
| 44 | Roivant SciencesROIV · Health Care | SAR 1.6B | SAR 106.7B | SAR 147.25 | 1.36% up | 91% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | SAR 1.6B | SAR 37.2B | SAR 245.93 | 0.84% down | 117% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | SAR 1.1B | SAR 18.2B | SAR 104.35 | 0.04% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 788.3M | SAR 30.5B | SAR 440.18 | 1.42% down | 18% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 735.3M | SAR 27.9B | SAR 355.37 | 0.33% down | 129% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | SAR 708.4M | SAR 26.7B | SAR 243.51 | 4.23% down | 10% down | ||
| 50 | ABIVAXABVX · Health Care | SAR 537.4M | SAR 27.3B | SAR 311.52 | 0.93% down | 32% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | SAR 404.3M | SAR 15.2B | SAR 110.95 | 1.58% up | 168% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | SAR 346.3M | SAR 32.5B | SAR 40.62 | 3.14% up | 36% down | ||
| 53 | ErascaERAS · Health Care | SAR 266.3M | SAR 19.2B | SAR 54.65 | 5.89% up | 395% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SAR 234.6M | SAR 35.3B | SAR 371.50 | 2.39% down | 332% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | SAR 224.2M | SAR 32.6B | SAR 1,168.01 | 2.03% up | 86% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | SAR 200.6M | SAR 30.5B | SAR 467.30 | 2.03% down | 51% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | SAR 140.7M | SAR 18.2B | SAR 322.92 | 2.51% up | 108% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | SAR 113.8M | SAR 17B | SAR 155.70 | 0.34% up | 86% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | SAR 62.6M | SAR 25.2B | SAR 372.29 | 3.67% up | 255% up | ||
| 60 | Belite BioBLTE · Health Care | SAR 37.8M | SAR 23.4B | SAR 576.57 | 1.61% down | 43% up | ||
| 61 | VeradermicsMANE · Health Care | SAR 34.3M | SAR 19.5B | SAR 462.05 | 1.35% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which health care pharmaceutical companies rank first by total liabilities?
AbbVie (SAR 514.6B), Pfizer (SAR 455.3B) and Johnson & Johnson (SAR 441.4B) are the top three of the 61 health care pharmaceutical companies ranked by total liabilities as of 19 Nov 2026, 18:32 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total liabilities have a combined market value of SAR 18.66T as of 19 Nov 2026, 18:32 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.